Vertex swung to a second-quarter loss of $961,000, or 1 cent a share, compared with a profit of $5.2 million, or 3 cents a share. Adjusted per-share earnings were 15 cents, beating analyst ...

Vertex Pharmaceuticals Inc. fell after an experimental pain drug failed to provide post-surgery benefits and US regulators ...